Sulforaphane Supplement Guide: Forms, Myrosinase & Human Evidence

A sulforaphane supplement is only useful to compare when you know what it is actually delivering. “Broccoli extract 500 mg,” “glucoraphanin 100 mg,” “sulforaphane 10 mg” and “glucoraphanin + active myrosinase” describe different chemical and delivery problems—not interchangeable doses.

The central human finding is simple: formulation is part of the dose. Preformed sulforaphane, precursor-only glucoraphanin, active myrosinase, raw versus cooked food, gastric delivery and gut conversion can all change how much sulforaphane reaches the body.

Editor’s rule: never rank a sulforaphane product by total broccoli-extract milligrams alone. First identify the chemical form, then the conversion system, then delivered exposure, and only then compare dose or health claims.

Sulforaphane supplements at a glance

What is sulforaphane—and why isn’t it simply “in broccoli”?

Broccoli and broccoli sprouts mainly store glucoraphanin, a glucosinolate precursor. When plant tissue is damaged by chewing, chopping or processing, the enzyme myrosinase can hydrolyze glucoraphanin and generate sulforaphane.

That conversion step is why two products can show similar-looking broccoli ingredients while producing very different internal exposure. It is also why “sulforaphane,” “glucoraphanin” and “broccoli sprout extract” should not be used interchangeably.

For the chemistry, see Sulforaphane vs Glucoraphanin. For the enzyme step, see Myrosinase & Sulforaphane.

The four major sulforaphane delivery formats

Administered dose vs delivered dose

A person can swallow the same nominal broccoli-derived dose and receive very different internal sulforaphane exposure. Human studies make this unusually clear.

Our dedicated Sulforaphane Bioavailability guide goes deeper into absorption, gut conversion, enteric coating and gastric conditions.

What does sulforaphane do in the body?

The most discussed mechanism is KEAP1–NRF2 stress-response signaling. Sulforaphane can modify KEAP1-related signaling and alter transcription of cytoprotective genes. Human biology is more complicated than the shorthand “activates NRF2.”

A dose-escalation study in healthy adults found increases in several Phase II response genes in nasal airway cells.^[6] In contrast, a randomized COPD trial found no significant increase in its prespecified airway NRF2 targets and no improvement in pulmonary-function or inflammatory endpoints despite measurable absorption.^[7]

See Sulforaphane & NRF2 for the positive-versus-null human evidence.

What human benefits are actually supported?

The human evidence is broad but uneven. The strongest conclusions depend on the endpoint.

For the full cross-condition synthesis, see Sulforaphane Benefits: Human Evidence Ranked by Strength.

How to read a sulforaphane supplement label

1. Identify the chemical form. Sulforaphane, glucoraphanin, “sulforaphane glucosinolate,” or only broccoli-extract weight?
2. If it is glucoraphanin, look for active myrosinase. This is one of the strongest human-supported delivery variables.
3. Check whether the active/precursor amount is disclosed. A large proprietary broccoli blend is hard to evaluate.
4. Do not confuse formula weight with delivered sulforaphane.
5. Look for potency and testing transparency. Ingredient theory is not the same as the finished product in your hand.
6. Match the evidence to the formulation. A trial on stabilized sulforaphane or Avmacol is not direct evidence for an unrelated product.

How much sulforaphane per day?

There is no universally established optimal daily dose, RDA or validated long-term upper intake level. Human studies use direct sulforaphane, glucoraphanin, broccoli sprout beverages and extracts reported in different units.

See the Sulforaphane Dosage guide for µmol-to-mg conversion, trial doses and the difference between precursor weight and delivered sulforaphane.

Is sulforaphane safe?

Short-term human studies are broadly reassuring for the preparations tested, but safety is also formulation- and dose-dependent. A one-week Phase I sprout-extract study found no significant or consistent toxicity attributable to the tested preparations.^[8] A 12-week study found no significant adverse changes in measured thyroid markers in the analyzed participants.^[9]

At higher pharmacologic exposure, a 2025 Phase I study of stabilized enteric-coated sulforaphane reported frequent treatment-emergent gastrointestinal events, although most were mild and transient.^[10]

See the complete Sulforaphane Side Effects & Safety guide.

Broccoli sprouts or a supplement?

Fresh broccoli sprouts are a credible food-based glucoraphanin–myrosinase system. Supplements can offer portability and standardization when the formulation discloses enough to estimate delivery.

The strongest human lesson is not “food wins” or “supplements win.” Fresh sprouts outperformed a myrosinase-free supplement in one direct crossover study,^[2] while defined enzyme-containing extracts can materially improve precursor conversion.^[3] Formulation beats category.

See Broccoli Sprouts vs Sulforaphane Supplements and Foods High in Sulforaphane.

Which supplement is best?

That is a separate buyer-intent question. Our Best Sulforaphane Supplements 2026 guide ranks products by delivery logic, myrosinase, disclosure, human research, testing and value rather than broccoli-extract milligrams.

Explore the Sulforaphane Data Center

Our Sulforaphane Data Center tracks 37 research papers across pharmacokinetics, food preparation, safety, pollutant biomarkers, metabolic disease, autism and schizophrenia, respiratory biology, H. pylori and cancer-related evidence. Positive, mixed and null trials are included so one study cannot be stretched into a claim it never tested.

Bottom line

A strong sulforaphane decision is not defined by the biggest broccoli number on a bottle. Start with the form being delivered, then conversion, then dose, then the human endpoint behind the claim. Human evidence clearly shows that active myrosinase, preparation and delivery design can change exposure several-fold. What it does not show is that higher bioavailability automatically produces every proposed health benefit.